IL166809D0
Pharmaceutical nati-tnf-alpha antibody formulation
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Published
- Today
4 priority claims, no other members on record
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 22214002 | United States of America | A | |
| 0304502 | International Bureau of the World Intellectual Property Organization (WIPO) | W | |
| US20020222140 | – | – | – |
| WO2003IB04502 | – | – | – |
4 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent renewedKB | KB | |
| Patent grantedGrantedFF | FF |
Numbers
- Publication, DOCDB
- 166809
- Publication, EPODOC
- IL166809D
- Application
- 166809
- Application, DOCDB
- 16680905
- Application, EPODOC
- IL20050166809
Titles
- English
- Pharmaceutical nati-tnf-alpha antibody formulation
Classification
- CPC, 53
- A61K39/39591
- A61K39/395
- C07K2317/21
- C07K16/241
- C07K2317/76
- A61K9/0019
- A61K47/26
- C07K2317/94
- A61P1/00
- A61P1/02
- A61P1/04
- A61P1/16
- A61P1/18
- A61P11/00
- A61P11/06
- A61P13/12
- A61P15/00
- A61P17/00
- A61P17/06
- A61P19/02
- A61P19/04
- A61P19/06
- A61P19/08
- A61P25/02
- A61P25/04
- A61P27/02
- A61P29/00
- A61P3/04
- A61P31/00
- A61P31/04
- A61P31/12
- A61P31/18
- A61P33/06
- A61P35/00
- A61P37/00
- A61P37/02
- A61P37/06
- A61P37/08
- A61P43/00
- A61P7/00
- A61P9/00
- A61P9/04
- A61P9/10
- A61P3/10
- Y02A50/30
- A61K9/19
- A61K2039/505
- C07K2317/92
- A61K39/3955
- A61K47/10
- A61K47/12
- A61K47/22
- A61K47/02
- IPC, 1
- A61K9 19